Webinar details

Thursday Feb 21, 2019

12:00 PM – 1:00 PM EST

The world of pharmacogenomics is changing fast. Join our panelists as they discuss the progress being made through Canadian pilot projects.

  • Scientific / clinical updates: Status of acceptance by physicians and pharmacists, and applicability for primary and specialist care physicians
  • Pharmacogenomics initiatives: Update on insurer pilot testing and government studies, all looking to measure the results on health outcomes
  • Legislation: Discussion on Canada’s new Genetic Non-Discrimination Act and what it means for private payers

This interactive session will also cover the impact these advances may potentially have on group health insurance plans, from an economic, health outcomes and coverage standpoint.

Dr. Michel Hébert
Medical Director, TELUS Health | Directeur médical, TELUS Santé

Patrick Charbonneau
Product Director, TELUS Health | Directeur, Gestion de produits, TELUS Santé

About PetalMD

"Initially, most doctors made only 30% of their time slots available online, fearing that this new channel would cause problems for seniors. We quickly discovered that these fears were unfounded, and now, 100% of time slots are available online."
- Julie D., Director at Saint-Louis Medical Clinic

Available On: PS Suite, Kinlogix, Med Access

PetalMD offers cloud-based technology solutions to simplify the lives of healthcare professionals. PetalBooking helps clinics improve their operational efficiency and patient experiences with an online patient booking portal, automated reminders and an analytics dashboard.